169 related articles for article (PubMed ID: 37761293)
1. Diagnostic Value of
Lao TD; Truong PK; Le TAH
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761293
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of methylated
Zhang J; Shen Z; Liu H; Liu S; Shu W
Cancer Manag Res; 2018; 10():2953-2964. PubMed ID: 30214290
[TBL] [Abstract][Full Text] [Related]
3. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
4. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
Jia W; Yu T; Cao X; An Q; Yang H
Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
[TBL] [Abstract][Full Text] [Related]
5. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
Cai F; Xiao X; Niu X; Zhong Y
PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the
Lao TD; Thieu HH; Nguyen DH; Le TAH
Int J Biol Markers; 2022 Mar; 37(1):31-39. PubMed ID: 34935528
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
Ye M; Huang T; Ni C; Yang P; Chen S
EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis.
Wang H; Zhou LY; Guan ZB; Zeng WB; Zhou LL; Liu YN; Pan XY
PLoS One; 2019; 14(1):e0210943. PubMed ID: 30682070
[TBL] [Abstract][Full Text] [Related]
9. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.
Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ
J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
[TBL] [Abstract][Full Text] [Related]
12. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
13. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
Zhang J; Yu XL; Zheng GF; Zhao F
Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.
Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
Int J Cancer; 2003 Jul; 105(6):851-5. PubMed ID: 12767073
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
[TBL] [Abstract][Full Text] [Related]
16. Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis.
Wu C; Peng S; Sun W; Luo M; Su B; Liu D; Hu G
Head Neck; 2018 Nov; 40(11):2538-2545. PubMed ID: 29947108
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
Qi M; Xiong X
Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis.
Zhang Y; Wu J; Huang G; Xu S
Cancer Manag Res; 2018; 10():6897-6904. PubMed ID: 30588095
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
Zheng XH; Li XZ; Zhou T; Jiang CT; Tang CL; Deng CM; Liao Y; He YQ; Wang TM; Jia WH
Int J Cancer; 2023 Jun; 152(12):2629-2638. PubMed ID: 36878711
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.
Li Y; Zhu M; Zhang X; Cheng D; Ma X
Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
